Words from our new Co-Chiefs: "It is an honor and a privilege to be entrusted by our co-residents and faculty to fill the chief resident role. We follow in the footsteps of past chiefs working in tandem with residency leadership to build a longstanding tradition of excellence. We are excited to work closely with our dedicated faculty and amazing co-residents to enhance the resident experience at Iowa and to advance our national reputation."

Researchers at the National Institutes of Health, led by Dr. Natalie Shaw, have found that a toxic protein made by the body called DUX4 may be the cause of two very different rare genetic disorders. For patients who have facioscapulohumeral muscular dystrophy (FSHD), or a rare facial malformation called arhinia, this research discovery may eventually lead to therapies that can help people with these rare diseases. Their latest publication is the subject of a February 17, 2023 NIH press release (https://www.niehs.nih.gov/news/newsroom/releases/2023/february17/index.cfm).

Drs. Legge and Waldschmidt, along with key collaborators, previously documented the ability of intranasally administered nanoparticle-based influenza vaccines to induce both homologous and heterologous protection against IAV infection. The current project will further optimize the nanoparticle-based influenza vaccine designed for intranasal administration.

Dr. Bing Li, the Endowed Professor in Cancer Immunology Research in the Department of Pathology, has been appointed Director of the newly formed Iowa Cancer and Obesity Initiative by the University of Iowa Holden Comprehensive Cancer Center.